Trapped Neutrophil Syndrome, TNS (Failure to Thrive in Collies) in Dogs

  • Occurrence: very rare
  • Location of illness: General/Whole body
Content
Download/Print

Trapped Neutrophil Syndrome (TNS) is a genetically determined disease that occurs particularly in Collies and impairs their ability to effectively produce and release white blood cells, especially neutrophils, leading to a weakened immune response.

The most important facts at a glance

Trapped Neutrophil Syndrome (TNS) is a genetic disease in Collies caused by a mutation in the GFI1 gene. This mutation prevents neutrophil granulocytes, a type of white blood cell, from leaving the bone marrow and entering the bloodstream, leading to immunodeficiency. TNS is inherited in an autosomal recessive manner, meaning that affected dogs need two copies of the mutated gene to show symptoms. Common symptoms include Diarrhea, conjunctivitis, and Skin infections, while rare symptoms may include Cough or Joint pain. Diagnosis is made by a blood count and can be confirmed by a genetic test. There is no specific cure, so treatment focuses on symptom relief and infection prevention. Antibiotics and supportive care are crucial, but the prognosis often remains unfavorable as the life expectancy of affected dogs is greatly reduced. Preventive measures include genetic testing in breeding dogs to prevent the transmission of the defective gene. Research focuses on improving diagnostics and developing potential genetic correction methods. Scientists are also investigating the role of environmental factors and working on international breeding protocols. The goal is to better understand the disease and enable affected dogs to live longer, healthier lives.

Causes

Trapped Neutrophil Syndrome is based on a genetic defect that impairs the maturation and release of neutrophils from the bone marrow into the bloodstream. Neutrophils are a type of white blood cell that plays a crucial role in fighting infections. In TNS, these cells remain “trapped” in the bone marrow, resulting in a reduced number in the blood.

The genetic defect in TNS is inherited in an autosomal recessive manner, meaning that an affected dog must inherit two copies of the mutated gene, one from each parent, to show symptoms of the disease. Dogs that carry only one copy of the mutated gene are carriers and do not show symptoms, but can pass the disease on to their offspring.

The causative genetic mutation in TNS affects the GFI1 gene, which plays an important role in regulating genes required for normal neutrophil maturation. Abnormal function of this gene causes the neutrophils to be retained in the bone marrow instead of entering the bloodstream where they could fight infections.

Symptoms

The symptoms of TNS usually occur in young Collies, often as early as puppyhood. Affected dogs often show signs of Failure to thrive, including growth retardation and weight loss. They may also show signs of immunodeficiency, such as recurrent infections of the respiratory tract, skin, or digestive tract.

Other common symptoms include Fever, lethargy, and general weakness. Due to the insufficient number of functioning neutrophils in the blood, affected dogs are susceptible to bacterial infections that can be severe and sometimes life-threatening.

In some cases, enlargement of the lymph nodes and spleen may occur as the body tries to compensate for the reduced function of the neutrophils. Blood count changes such as anemia can also be observed.

Diagnosis

The diagnosis of Trapped Neutrophil Syndrome usually begins with a thorough clinical examination and a detailed medical history to evaluate the symptoms and the course of the disease. However, due to the non-specific symptoms, a definitive diagnosis can be difficult.

A complete blood count is crucial to determine the number of neutrophils. In TNS, the blood count typically shows neutropenia, i.e. a reduced number of neutrophils. Other abnormalities such as anemia can also be detected.

To confirm the diagnosis, a genetic test can be performed to detect the presence of the specific mutation in the GFI1 gene that is responsible for TNS. This test is particularly useful for distinguishing affected dogs from non-affected carriers.

Therapy

A causal therapy for Trapped Neutrophil Syndrome does not currently exist. Treatment therefore focuses on alleviating the symptoms and supporting affected dogs in coping with infections.

Antibiotics can be used to treat and prevent bacterial infections that commonly occur due to reduced immune function. In severe cases, intravenous antibiotic therapy may be necessary.

Supportive care, including a nutritious diet and regular veterinary care, is crucial to improve the overall well-being of affected dogs. In some cases, immunostimulants or growth factors may be considered, although their effectiveness is limited.

Prognosis and follow-up care

The prognosis for dogs with Trapped Neutrophil Syndrome is generally unfavorable. Most affected dogs develop severe infections in puppyhood that are often untreatable. Life expectancy is usually severely shortened, and many dogs die or must be euthanized before reaching adulthood.

The severity of symptoms can vary from dog to dog, even if the genetic mutation is identical. Some dogs have a relatively better quality of life if diagnosed early and treated adequately, but the long-term prognosis remains difficult.

Prevention

The most effective method of preventing Trapped Neutrophil Syndrome is genetic testing of breeding animals. Through the use of genetic tests, carriers of the disease can be identified and excluded from breeding to prevent the transmission of the defective gene.

Responsible breeding management, including avoiding inbreeding and carefully selecting breeding pairs, can significantly reduce the risk of giving birth to affected puppies.

Education and awareness in the breeder community are also crucial to improve understanding of this genetic disease and to promote the necessary measures for control and prevention.

Outlook on current research

Research into Trapped Neutrophil Syndrome (TNS) in Collies has made significant progress in recent years. TNS is a genetic disease caused by a mutation in the GFI1 gene. This mutation prevents neutrophil granulocytes, a type of white blood cell, from leaving the bone marrow and entering the bloodstream. The disease leads to immunodeficiency, which makes affected dogs susceptible to infections. Current studies focus on understanding the genetic mechanism and molecular basis of this disease.

Much of the current research focuses on improving diagnostic methods and developing ways to correct genes. Genetic tests are already available and help breeders control the spread of the disease. Scientists are also exploring the possibility of gene therapy as a potential treatment method. This therapy could theoretically replace the defective gene copy with a functioning one, which could alleviate or possibly cure the symptoms of the disease.

In addition, the role of environmental factors and other genetic predispositions that can influence the severity of the disease is being investigated. Researchers are working to create more comprehensive genetic profiles that could help to better predict the risk of TNS in Collies. Such profiles could enable breeders to make more targeted decisions to further reduce the spread of the disease.

There are also efforts to establish internationally standardized protocols for breeding Collies to minimize the risk of spreading TNS. These protocols include the use of genetic testing as a standard procedure in the breeding of Collies. Collaboration between international research groups is crucial to preserve the genetic diversity of the breed while protecting the health of the animals.

Another area of research is the development of therapeutic approaches that focus on strengthening the immune system of affected dogs. Experimental treatments that support the immune system could help improve the quality of life of dogs and reduce susceptibility to infections. Such therapies may prove useful when used in conjunction with genetic correction measures.

In summary, research into TNS in Collies is heading in a promising direction. The development of new diagnostic and therapeutic approaches could lead to better management strategies for this disease in the near future. This could enable affected dogs to live longer and healthier lives.

Frequently asked questions (FAQs)

  1. What is Trapped Neutrophil Syndrome (TNS) in Collies? TNS is a genetic disease that occurs in Collies and is caused by a mutation in the GFI1 gene. This mutation prevents neutrophil granulocytes, a type of white blood cell, from leaving the bone marrow and entering the bloodstream. This leads to an immunodeficiency that makes the dogs susceptible to infections.

  2. How is TNS diagnosed? TNS is mainly diagnosed by genetic tests that can detect the specific mutation in the GFI1 gene. These tests are particularly important for breeders to identify affected animals and prevent the spread of the disease.

  3. Can all Collies be affected by TNS? Yes, theoretically all Collies can be affected by TNS, as the disease is genetic. The likelihood of a dog being affected depends on the genetic makeup of the parents. However, genetic testing before breeding can minimize the risk.

  4. What symptoms occur in dogs with TNS? Dogs with TNS often show symptoms of immunodeficiency, such as recurrent infections, Growth disorders, and general weakness. The disease can also lead to Refusal to eat, Weight loss, and a reduced life expectancy.

  5. Is there a cure for TNS? There is currently no cure for TNS. Treatment focuses on alleviating the symptoms and supporting the immune system. However, research is being carried out into possibilities for gene therapy, which could enable a cure in the future.

  6. How can TNS be prevented in Collies? TNS can be prevented through responsible breeding practices that use genetic testing to identify carriers of the mutation. Breeders should only breed dogs that are not carriers of the mutation to prevent the spread of the disease.

  7. Are all Collie breeds affected by TNS? TNS is primarily known in the Longhaired Collie, but can also occur in other Collie breeds. It is important that breeders of all Collie breeds consider genetic testing, especially if cases of TNS are known in the pedigree.

  8. How common is TNS in Collies? The exact frequency of TNS in Collies is not fully known, but varies depending on the region and breeding population. However, genetic testing and responsible breeding practices can significantly reduce the frequency of the disease.

  9. What support is available for owners of dogs with TNS? Owners of dogs with TNS should work closely with their veterinarian to develop a treatment plan that alleviates their dog’s symptoms. There are also specialized veterinary clinics and research centers that can offer support in the care of affected dogs.

  10. Is there hope for future treatments for TNS? Yes, research is making progress in the development of gene therapies and other innovative treatment approaches that could improve the management and treatment of TNS in the future. These advances offer hope for affected dogs and their owners.

Content
Download/Print